Showing 49–64 of 71 resultsSorted by popularity
Dutasteride is a dual Type I and Type II 5-alpha-reductase inhibitor that reduces systemic DHT levels by over 90%, surpassing Finasteride’s single-isoenzyme selectivity. A thorough research tool for investigating maximal androgen blockade in DHT-sensitive tissues.
Enclomiphene (Androxal) is the purified trans-isomer of clomiphene that acts as a pure estrogen receptor antagonist at the pituitary, potently stimulating endogenous LH and FSH secretion without the mixed agonist properties of zuclomiphene. A go-to HPTA restoration research tool.
5-Amino-1MQ is a potent NNMT inhibitor that prevents nicotinamide methylation, diverting it into the NAD+ salvage pathway to elevate intracellular NAD+ and activate SIRT1. An oral formulation for investigating metabolic remodeling and adipose tissue reduction.
A dnp research tool. The biochemical activity of DNP is defined by its ability to act as a proton ionophore within the mitochondria.
Prednisone is a glucocorticoid prodrug that undergoes hepatic conversion to active prednisolone, which binds cytosolic glucocorticoid receptors to translocate into the nucleus and repress NF-kB-driven pro-inflammatory gene transcription.
M1T (17a-Methyl-1-testosterone) is a highly potent C17-alpha-alkylated DHT derivative that delivers exceptional anabolic signaling through direct androgen receptor activation. A primary research compound for studying extreme nitrogen retention and rapid muscle hypertrophy.
Salbutamol is a selective Beta-2 adrenergic receptor agonist that activates adenylate cyclase to increase cAMP levels, driving both bronchodilation and lipolysis. A research tool for investigating adrenergic signaling in respiratory and metabolic models.
Halotestin (Fluoxymesterone) is an extremely potent C17-alkylated androgen featuring 9-alpha-fluoro and 11-beta-hydroxy modifications that maximize androgen receptor binding while preventing aromatization. A trusted compound for investigating central nervous system androgenic signaling.
Letrozole (Femara) is a non-steroidal Type II aromatase inhibitor that competitively coordinates with the CYP19A1 heme iron, reversibly blocking androgen-to-estrogen conversion. A high-potency research tool for achieving strong estrogen suppression.
Flibanserin is a multifunctional serotonin ligand that acts as a 5-HT1A agonist and 5-HT2A antagonist, shifting the neurochemical balance to increase dopamine and norepinephrine while reducing serotonin inhibition. A targeted tool for female libido and neurotransmitter research.
Myostatin inhibitor SARM for muscle growth research. Study follistatin upregulation and AR activation.
Andarine (S4) is a tissue-selective SARM that binds the androgen receptor with high affinity and preferentially activates androgen response elements in skeletal muscle and bone over prostate tissue. Its 4-hour half-life requires optimized dosing protocols.
AICAR is a cell-permeable nucleoside analog that converts intracellularly to ZMP, potently activating AMPK to mimic exercise-induced metabolic stress. An oral formulation for investigating mitochondrial biogenesis and insulin-independent glucose disposal.
SR9009 is a Rev-ErbA nuclear receptor agonist that suppresses BMAL1 and CLOCK gene transcription to reprogram circadian metabolic rhythms. It upregulates mitochondrial biogenesis and fatty acid oxidation in skeletal muscle, functioning as an exercise mimetic.
DHB (1-Testosterone) is a potent 5-alpha reduced androgen with a 1-ene double bond that enhances anabolic potency while being immune to aromatization and 5-alpha reductase conversion. It delivers pure, dry myofibrillar protein synthesis signaling.
Primary androgen for AR activation and anabolic signaling research. Study protein synthesis and nitrogen retention.
End of content
End of content
No products in the cart.
